Introduction:
  Anterferon is a lind of E.coli-derived recombinant human Interferon α2b for injection which is a highly purified by advanced Monoclonal Affinity Chromatograph technology developed by Anhui Anke Biotechnology Co.,Ltd.
  Anterferon is the first Recombinant Human Interferon α2b for Injection licensed by National Drug Administration. Anterferon has won the title of “the Nation’s Key Novel Product”, “Contribution Prize” by Anhui provincial Government.
Function:
  Anterferon is a sterile, white, lyophilized power for administration after reconstitution with 1ml Bacteria static water for injection per vial, inhibiting provides a wide spectrum of anti-viral, inhibiting proliferation of tumor cell and increasing immunity such as treatment of hepatitis, leukemia and a variety of cancers. The clinical testing and application have demonstrated that recombinant human interferon has significant therapeutically effect on more than 30 kinds of important human disease.